157 related articles for article (PubMed ID: 9315418)
21. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
Weir SS; Roddy RE; Zekeng L; Feldblum PJ
Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
[TBL] [Abstract][Full Text] [Related]
22. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
Mayersak JS; Viviano CJ
J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
[TBL] [Abstract][Full Text] [Related]
23. Comparative trial between two soft jelly capsules containing nonoxynol as spermicidal contraceptives.
Bassol S; Recio R; de la Cruz DL
Contraception; 1989 Apr; 39(4):409-18. PubMed ID: 2541967
[TBL] [Abstract][Full Text] [Related]
24. Acute urinary retention secondary to urethral inflammation from a vaginal contraceptive suppository in a 17-year-old boy.
Saborio DV; Kennedy WA; Hoke GP
Urol Int; 1997; 58(2):128-30. PubMed ID: 9096278
[TBL] [Abstract][Full Text] [Related]
25. The effectiveness of barrier methods of contraception with and without spermicide.
Craig S; Hepburn S
Contraception; 1982 Oct; 26(4):347-59. PubMed ID: 6759027
[TBL] [Abstract][Full Text] [Related]
26. Experiences with a tampon-spermicide device.
Page EW
Contraception; 1981 Jan; 23(1):37-44. PubMed ID: 7193551
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of vaginally administered nonoxynol-9 in premenopausal women.
Barditch-Crovo P; Witter F; Hamzeh F; McPherson J; Stratton P; Alexander NJ; Trapnell CB
Contraception; 1997 Apr; 55(4):261-3. PubMed ID: 9179459
[TBL] [Abstract][Full Text] [Related]
28. Intravaginal and intracervical devices for the delivery of fertility regulating agents.
J Steroid Biochem; 1979 Jul; 11(1B):461-7. PubMed ID: 491617
[TBL] [Abstract][Full Text] [Related]
29. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
[TBL] [Abstract][Full Text] [Related]
30. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
Ahmad M; Asch RH
Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of gramicidin and EDTA in inhibiting sperm motility and cervical mucus penetration in vitro.
Bourinbaiar AS; Lee CH
Contraception; 1996 Dec; 54(6):367-72. PubMed ID: 8968665
[TBL] [Abstract][Full Text] [Related]
32. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
[TBL] [Abstract][Full Text] [Related]
33. Comparative vaginal spermicidal studies in the stumptailed macaque with alkyloxynol-741, nonoxynol-9 and chlorhexidine.
Diao XH; Zou S; Quigg J; Kaminski J; Zaneveld LJ
Contraception; 1990 Dec; 42(6):677-82. PubMed ID: 1964633
[TBL] [Abstract][Full Text] [Related]
34. Nonprescription vaginal contraception.
Edelman DA
Int J Gynaecol Obstet; 1980; 18(5):340-4. PubMed ID: 6110578
[TBL] [Abstract][Full Text] [Related]
35. Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
Mohsenian M; Moghissi KS; Borin K
Contraception; 1981 Aug; 24(2):173-81. PubMed ID: 7297068
[TBL] [Abstract][Full Text] [Related]
36. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
37. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
38. Spermicide permeation through biocompatible polymers.
Saltzman WM; Tena LB
Contraception; 1991 May; 43(5):497-505. PubMed ID: 1655352
[TBL] [Abstract][Full Text] [Related]
39. Effect of nomegestrol acetate on spinability, ferning and mesh dimension of midcycle cervical mucus.
Chretien FC; Dubois R
Contraception; 1991 Jan; 43(1):55-65. PubMed ID: 2004529
[TBL] [Abstract][Full Text] [Related]
40. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
